Latest Breaking News On - Company takeaim leukemia - Page 1 : comparemela.com

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

United statesRoche erivedgeJames dentzerDrug administrationCuris incExchange commissionPrnewswire curis incRoche groupCompany takeaim leukemiaTakeaim leukemiaRecommended phaseChief executive officerRecent operationalComplete remissionPartial hematologicObjective response